Literature DB >> 82510

The in vitro immune response to a T-independent antigen. I. The effect of macrophages and 2-mercaptoethanol.

A A Nordin.   

Abstract

The in vitro immune response of murine spleen cells to the T cell-independent antigen, 2,4-dinitrophenyl-beta-alanyl-glycyl-glycyl-N(2-aminoethyl)carbamyl-methylated Ficoll (DAGG-Ficoll), requires the presence of macrophages, or 24-hr culture supernates from peritoneal cells. Complete reconstitution of the response by supernates, however, is dependent on the addition of 2-mercapto-ethanol. Antigen is required to fully express the in vitro immune response, but is not required in cultures of peritoneal cells in order to obtain active supernates. Active supernates can be obtained from allogeneic or syngeneic peritoneal cell cultures. The enhancing effects of 2-mercaptoethanol and peritoneal cell supernates appear to be synergistic nonspecific events directed toward lymphocyte activation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82510     DOI: 10.1002/eji.1830081105

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Rise in inulin-sensitive B cells during ontogeny can be prematurely stimulated by thymus-dependent and thymus-independent antigens.

Authors:  R D Shahin; J J Cebra
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

2.  Primary in vitro plaque-forming cell response to DAGG-Ficoll: LPS-induced enhancement mediated by interleukin-1.

Authors:  J L Curtis; A A Nordin
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

3.  Improved serum-free culture conditions for the differentiation of human and murine fibrocytes.

Authors:  Darrell Pilling; Varsha Vakil; Richard H Gomer
Journal:  J Immunol Methods       Date:  2009-10-08       Impact factor: 2.303

4.  The requirement for adherent cells in the Fc fragment-induced proliferative response of murine spleen cells.

Authors:  E L Morgan; W O Weigle
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.